The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| STAA | -8.2% | -62.49% | -17.8% | +10% |
| S&P | +13% | +86.41% | +13.26% | +4,021% |
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Staar Surgical's sales grew, but it delivered mixed signals on profitability.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $94.73M | 6.9% |
| Gross Profit | $76.63M | 11.9% |
| Gross Margin | 80.89% | 3.6% |
| Market Cap | $1.33B | -27.4% |
| Market Cap / Employee | $1.10M | 0.0% |
| Employees | 1.2K | 8.6% |
| Net Income | $8.88M | -11.0% |
| EBITDA | $46.49M | 524.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $176.16M | 7.4% |
| Accounts Receivable | $60.11M | -42.5% |
| Inventory | 53.3 | 32.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $33.80M | -4.5% |
| Short Term Debt | $5.31M | 15.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -19.39% | -23.7% |
| Return On Invested Capital | 4.56% | -2.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $1.78M | 173.9% |
| Operating Free Cash Flow | $2.67M | -30.1% |
| Metric | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 72.20 | 123.76 | 142.12 | 84.98 | - |
| Price to Book | 2.80 | 2.19 | 2.37 | 3.93 | -7.97% |
| Price to Sales | 3.80 | 3.14 | 3.73 | 5.87 | 8.27% |
| Price to Tangible Book Value | 2.81 | 2.20 | 2.39 | 3.96 | -7.87% |
| Price to Free Cash Flow TTM | 89.67 | 175.02 | 70.41 | - | |
| Enterprise Value to EBITDA | -39.20 | -12.56 | -30.28 | 25.84 | -88.39% |
| Free Cash Flow Yield | 1.1% | 0.6% | 1.4% | - | |
| Return on Equity | -5.2% | -19.1% | -25.6% | -24.6% | -556.58% |
| Total Debt | $38.74M | $36.68M | $40.52M | $39.12M | -2.21% |
No podcast episodes available.
STAA earnings call for the period ending September 30, 2021.
STAA earnings call for the period ending June 30, 2021.
STAA earnings call for the period ending March 31, 2021.
STAA earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
